You are here
Thursday, March 31, 2011
NIH study identifies gene that suppresses cell’s immune activation
The Journal of Clinical Investigation has retracted the article, "FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer ."
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®